Clinical characteristics of COVID-19 associated vasculopathic diseases

Coronavirus disease 19 (COVID-19) has shown to be an infectious disease affecting not only of the respiratory system, but also cardiovascular system leading to different COVID-19-associated vasculopathies. Venous and arterial thromboembolic events have been frequently described among hospitalized pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Greistorfer, Thiemo, Jud, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209947/
https://www.ncbi.nlm.nih.gov/pubmed/37231476
http://dx.doi.org/10.1186/s12959-023-00504-4
_version_ 1785046974088609792
author Greistorfer, Thiemo
Jud, Philipp
author_facet Greistorfer, Thiemo
Jud, Philipp
author_sort Greistorfer, Thiemo
collection PubMed
description Coronavirus disease 19 (COVID-19) has shown to be an infectious disease affecting not only of the respiratory system, but also cardiovascular system leading to different COVID-19-associated vasculopathies. Venous and arterial thromboembolic events have been frequently described among hospitalized patients with COVID-19 and inflammatory vasculopathic changes have also been observed. Several of the reported COVID-19 associated vasculopathies exhibit differences on epidemiology, clinical characteristics and outcome compared to non-COVID-19 types. This review focuses on the epidemiology, clinical, diagnostic and therapeutic characteristics as well as outcome data of COVID-19 associated thromboembolic events and inflammatory vasculopathies, elaborating similarities and differences with non-COVID-19 cohorts.
format Online
Article
Text
id pubmed-10209947
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102099472023-05-26 Clinical characteristics of COVID-19 associated vasculopathic diseases Greistorfer, Thiemo Jud, Philipp Thromb J Review Coronavirus disease 19 (COVID-19) has shown to be an infectious disease affecting not only of the respiratory system, but also cardiovascular system leading to different COVID-19-associated vasculopathies. Venous and arterial thromboembolic events have been frequently described among hospitalized patients with COVID-19 and inflammatory vasculopathic changes have also been observed. Several of the reported COVID-19 associated vasculopathies exhibit differences on epidemiology, clinical characteristics and outcome compared to non-COVID-19 types. This review focuses on the epidemiology, clinical, diagnostic and therapeutic characteristics as well as outcome data of COVID-19 associated thromboembolic events and inflammatory vasculopathies, elaborating similarities and differences with non-COVID-19 cohorts. BioMed Central 2023-05-25 /pmc/articles/PMC10209947/ /pubmed/37231476 http://dx.doi.org/10.1186/s12959-023-00504-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Greistorfer, Thiemo
Jud, Philipp
Clinical characteristics of COVID-19 associated vasculopathic diseases
title Clinical characteristics of COVID-19 associated vasculopathic diseases
title_full Clinical characteristics of COVID-19 associated vasculopathic diseases
title_fullStr Clinical characteristics of COVID-19 associated vasculopathic diseases
title_full_unstemmed Clinical characteristics of COVID-19 associated vasculopathic diseases
title_short Clinical characteristics of COVID-19 associated vasculopathic diseases
title_sort clinical characteristics of covid-19 associated vasculopathic diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209947/
https://www.ncbi.nlm.nih.gov/pubmed/37231476
http://dx.doi.org/10.1186/s12959-023-00504-4
work_keys_str_mv AT greistorferthiemo clinicalcharacteristicsofcovid19associatedvasculopathicdiseases
AT judphilipp clinicalcharacteristicsofcovid19associatedvasculopathicdiseases

Ejemplares similares